Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine in women with alcohol use disorder
NCT03137082Phase 2Completed
- Sponsor
- Stony Brook University
- Start
- Jul 2017
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Guanfacine XR with Placebo (2 arms). Primary endpoints: Percentage of Days Abstinent at 12 weeks, Percentage of Heavy Drinking Days at 12 weeks and 1 more. Started Jul 2017; status: completed.
02
Drugs
guanfacine
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03137082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03137082.